Menu
Not yet recruiting NCT06708728

Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients

— Observational Hemolytic Anemia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: blood samples.
Who it may be relevant to
Registry conditions: Hemolytic Anemia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease

Overview

the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases. And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.

Interventions

  • Other blood samples
    blood samples for CBC parameters , peripheral blood smear, bilirubin levels and kidney function tests

Primary outcome measures

  • intensive care unit admission of the patients due to progression of the disease complications. [Time frame: through study completion, an average of 6 months]
Secondary outcome measures (1)
  • mortality within duration of hospital admission [Time frame: through study completion, an average of 6 months]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 years and older.
  • Patients diagnosed with acquired hemolytic anemia.
  • Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
  • Patients (or their legal representatives) must provide informed

Exclusion criteria

  • Patients with underlying neoplastic diseases.
  • Patients with hereditary hemolytic anemia.
  • Patients or their representatives who do not consent to participate in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Egypt · 1 center
  • Faculty of Medicine Sohag University — Sohag

Identifiers

NCT: NCT06708728 · AEMahmoud

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗